Capital Research Global Investors - QIAGEN NV ownership

QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 17 filers reported holding QIAGEN NV in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Capital Research Global Investors ownership history of QIAGEN NV
ValueSharesWeighting
Q2 2018$79,285,000
+12.8%
2,176,055
+0.0%
0.02%
+10.0%
Q1 2018$70,268,000
+3.4%
2,175,8770.0%0.02%0.0%
Q4 2017$67,944,000
-0.8%
2,175,8770.0%0.02%
-4.8%
Q3 2017$68,516,000
-5.3%
2,175,8770.0%0.02%
-8.7%
Q2 2017$72,381,000
+14.6%
2,175,8770.0%0.02%
+15.0%
Q1 2017$63,161,000
-0.4%
2,175,877
-3.7%
0.02%
-4.8%
Q4 2016$63,393,0002,259,5650.02%
Other shareholders
QIAGEN NV shareholders Q4 2016
NameSharesValueWeighting ↓
Hardman Johnston Global Advisors LLC 4,177,260$158,235,0006.82%
Exane Asset Management 522,037$19,742,931,0006.18%
Tikvah Management LLC 442,942$16,779,0005.01%
Opus Point Partners Management, LLC 31,620$1,198,0002.86%
EDMOND DE ROTHSCHILD HOLDING S.A. 2,600,672$98,144,0002.79%
RTW INVESTMENTS, LP 775,324$29,369,0001.76%
SANDLER CAPITAL MANAGEMENT 787,529$29,832,0001.51%
FRIESS ASSOCIATES LLC 531,900$20,148,0001.40%
Sivik Global Healthcare LLC 85,000$3,220,0001.15%
Parametrica Management Ltd 11,940$452,0000.99%
View complete list of QIAGEN NV shareholders